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Int J Geriatr Psychiatry. 2020;35:3–11.Objectives: A systematic review of the relationship between subclinical small ves-
sel disease (SSVD) in the general population and apathy to examine the hypothesis
that apathy has a vascular basis.
Methods: We searched for studies on associations between apathy and SSVD,
operationalized as white matter hyperintensities (WMH) or white matter diffusivity
changes, lacunar infarcts, cerebral microbleeds, decreasing cortical thickness, and
perivascular spaces, while also peripheral proxies for SSVD were considered, opera-
tionalized as ankle brachial pressure index (ABI), intima media thickness, arterial stiff-
ness, cardio‐femoral pulse wave velocity, hypertension, or cardiovascular disease.
Only eligible retrospective and prospective observational studies conducted in the
general population were included.
Results: The 14 studies eligible for review examined the associations between apa-
thy and hypertension (3), ABI (1), arterial stiffness (1), cardiovascular disease (2),
WMH (3), white matter diffusivity (2), cerebral microbleeds (1), or cortical thickness
(3). Arterial stiffness and white matter diffusivity were not related to apathy, while
the associations with cortical thickness were contradictory. Cross‐sectional studies
in the general population did find evidence of apathy being associated with WMH,
CM, cardiovascular disease, hypertension, and ABI, and cardiovascular disease was
prospectively associated with apathy. The methodologies of the studies reviewed
were too heterogeneous to perform meta‐analyses.
Conclusions: Although more prospective evidence is needed and vascular depres-
sion needs to be controlled for, cardiovascular disease, hypertension, and ABI as
proxies for SSVD, and WMH and cerebral microbleeds as direct measures of SSVD
have been found to be associated with apathy in the general population, supporting
the hypothesis of vascular apathy.
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Key points
• Hypertension and cardiovascular disease, proxies for
SSVD, are associated with apathy.
• White matter hyperintensities, a direct measure of SSVD,
are associated with apathy.
• Prospective evidence of the associations between SSVD
and apathy is scarce.
• Further research into the SSVD‐apathy relationship from
prospective studies is warranted, preferably controlled
for depression.
WOUTS ET AL.41 | INTRODUCTION
Apathy, or diminished motivation, has traditionally been regarded as a
symptom of psychiatric and neurological disorders, such as major
depressive disorder1 and Parkinson's disease.2 Apathy has increasingly
come to be regarded as an independent syndrome for which diagnostic
criteria have been proposed in a consensus paper.3,4With its prevalence
in the general population (≥50 years) being estimated5 at 23.7%, the
impact of apathy on both individuals and the society is extensive. The
apathy syndrome negatively affects motivational decision making6 and
is associated with functional decline,5 reduced engagement in activities
of daily living, and a poorer quality of life.7 Understandably, apathy is
very distressing for family and other caregivers.8
The hypothesis of vascular apathy assumes a relationship between
the generally widespread cerebrovascular damage caused by small
vessel disease (SVD) and apathy.9,10 Whether cerebrovascular damage
due to SVD is associated with apathy—even in the general population
without prior knowledge of cerebrovascular damage—is the main sub-
ject of this study.
Various brain circuits play a role in planning, motivation, and
autoactivation; among which are the frontal regions with their projec-
tions to prefrontal regions and the basal ganglia, the parietal regions,
and the anterior cingulate.11 The vascular apathy hypothesis then sup-
poses that SVD can cause apathy by damaging these tracts. However,
the relationship between vascular disease and apathy could well be
bidirectional: A recent systematic review and meta‐analysis12 showed
that apathy increases the risk of myocardial infarction by 21%, stroke
by 37%, and even mortality by 47%. In the populations evaluated,
these risks might additionally or alternatively be raised because of
the participants' adverse health behaviors and low adherence to treat-
ment regimens for vascular disease.13-15 Moreover, apathy and vascu-
lar disease might have a shared etiology,16 while apathy could well be
a marker of subclinical SVD (SSVD).14
Early evidence for the vascular apathy hypothesis was reported in
studies in clinical samples with established cerebrovascular disease
(eg, vascular dementia and stroke), where apathy appeared related to
the general effect (or severity) of cerebrovascular damage, given that
associations with specific cerebral circuitries and regions were incon-
sistent.17,18 Particularly, the stroke subtype of SVD (lacunar infarcts
and white matter hyperintensities [WMH]) was found to be related
to apathy in several other studies, independent of depression.19-21
Indirect and also contradictory evidence came from research into
late‐life depression, where chronicity of late‐life depression was found
to be associated with the severity of the risk factors for cerebrovascular
disease and apathy.22 Still, although the presence of apathy was pre-
dicted by vascular factors in several elderly depressed populations,23
other studies found no such associations.1,24 Moreover, depression
itself could be related to vascular factors, as the so‐called vascular
depression hypothesis postulates,25 which complicates the interpreta-
tion of findings pertaining to vascular apathy in depressed populations.
Other indirect evidence seems to support the existence of vascular
apathy in that a negative interaction was observed between neuroti-
cism and cerebrovascular risk factors in the prediction of depression,suggesting that apathy caused by SSVD might attenuate the
depressogenic effect of neuroticism.10,26
Obviously, more convincing and direct evidence of vascular apathy
could come from research investigating the apathy‐SSVD relationship
in the general population, given that cerebral SVD develops from a
subclinical condition, increasing the risk on overt cerebrovascular dis-
ease,27-30 where, although still subclinical, SSVD might cause subtle
signs and symptoms, like mild disturbances in gait, cognitive function-
ing, and mood.27
The aim of the present systematic review is to examine all the evi-
dence supporting an association between SSVD and apathy in the
general population, while also considering findings of associations
between proxies of SSVD and apathy.2 | METHODS
2.1 | Literature search process
All eligible articles were found using Ovid‐all resources (which include
the Cochrane Library, EMBASE, MEDLINE, and PSYCHINFO), limits:
English, humans. The search terms were vascular apathy, and apathy
combined with deep WMH, WMH, cerebrovascular disease (not
stroke) (CV disease), lacunar infarcts, cerebral microbleeds, cortical
thickness, perivascular spaces, ankle brachial pressure index (ABI),
intima media thickness (IMT), arterial stiffness, cardio‐femoral pulse
wave velocity (CFPWV), hypertension, cardiovascular disease, and
cerebrovascular risk factors (CVRF). Duplicates were removed.
The search was conducted on June 27, 2018, by the first author (LW)
and checked by the second author (MvK). Differences in findings were
analyzed, and discrepancies were discussed between both authors (LW
and MvK), and when no consensus could be reached, a third author
(RM) was asked to make the final judgment. Two more eligible articles
were identified while preparing a speech on apathy using the search
terms “apathy” and “dementia.”31,44 On inspection, these two studies
also reported on the general population or populations with minimal cog-
nitive impairment (MCI), which is why we included them in our review.
Articles were included when (a) apathy was assessed by any kind
of relevant instrument; (b) SSVD was based on either neuroimaging,
WOUTS ET AL. 5considered a direct measure of SSVD, or peripheral measures of ath-
erosclerosis, considered as proxies for SSVD; and (c) studies reported
on observational epidemiological research and (d) were performed in
the general population. This implies that studies in broad patient
groups or the general population including those with minimally cogni-
tively impaired patients were included in the review.
Studies were excluded (a) when the language was not English and
(b) when the studies concerned specific populations, such as post‐
stroke patients and patients with dementia (including vascular demen-
tia), with Parkinson's disease, or with major depression.
2.2 | Study quality
The quality of the case‐control, cross‐sectional, and longitudinal stud-
ies selected for review was judged against specific criteria for design
and methodology. We used an adapted version of the evaluation scale
for cross‐sectional (not case‐control) studies originally developed by
Kuijpers et al32 (Data S1). For case‐control and longitudinal studies,
we used scales based on the Newcastle‐Ottawa scale33 (Data S2).
Overall quality of a study was considered high when it attained at least
60% of the maximum score.34
2.3 | Evaluation of the quality of apathy scales
The apathy evaluation scale (AES) and the apathy subscale of the neu-
ropsychiatric inventory (NPI) were considered of high quality.35,36 The
three apathy items of the geriatric depression scale are validated by
comparison with the apathy scale (sensitivity 69% and specificity
85%).29,37 The apathy scale (an abbreviated version of the AES) and
therefore also the apathy items of the GDS were not granted the
highest quality status in our evaluation based on the review by Clarke
et al.36 Clinician‐ or informant‐based information was considered of
higher quality than self‐reported in the older population where indi-
viduals may have been suffering from MCI.38
2.4 | Evaluation of the quality of SSVD assessment
SSVD on neuroimaging was operationalized as WMH, silent lacunar
infarcts, cerebral microbleeds, or decreased cortical thickness on MRI
scans.27 Diffusion tensor imaging (DTI) studies the diffusivity of water
molecules in white matter as a model of the connectivity of this tissue
and its markers (fractional anisotropy [FA] and diffusivity) are associ-
ated with SVD.39
Peripheral measures of atherosclerosis were operationalized as the
ABI, IMT, and/or CFPWV. Although the ABI and CFPWV are measures
of large artery atherosclerosis,40 we considered both measures proxies
for SSVD as large artery and SVD are closely related.41 Cardiovascular
diseasewas included as an SSVDproxy, since it can lead to hemodynamic
changes affecting the small vessels.41 Finally, being the strongest risk fac-
tor for SSVD, hypertension was also taken as an SSVD proxy.27,41
Studies were awarded an extra point if SSVD proxies were mea-
sured rather than mentioned in an interview or derived from informa-
tion provided by general practitioners. Self‐reported SSVD was
categorized as “low quality.”3 | RESULTS
The results of the search strategy are shown in the flow chart depicted
in Figure 1. No relevant studies published before 1990 were found. Of
the 14 studies included in the review, one study reported on both
peripheral proxies and direct measures of SSVD,30 four studies on
peripheral proxies of SSVD only,9,29,42,43 and finally, nine studies on
direct measures of SSVD only.31,44-51
3.1 | SSVD and apathy
In Table 1, the five studies that used peripheral proxies for SSVD are
listed and details and results are described. A meta‐analysis of the results
was not possible, because the research designs, SSVD proxies, and
methods of ascertaining apathy that had been used differed too widely.
Three studies examined associations between hypertension and
apathy9,30,42; two of which found a significant link with systolic blood
pressure,9,42 and the other with the diastolic (but not systolic) blood
pressure.30 This latter study30 also examined the association between
WMH and apathy by neuroimaging, of which the results are presented
in Section 3.2.
In their large‐scale study, Ligthart et al9 found an odds ratio (OR) of
1.28 in their participants with cardiovascular disease (1.09‐1.52;
P = .004). The number of cardiovascular pathologies in another large
and prospective study29 was found to be associated with apathy at
baseline and with incident apathy during follow‐up.
Finally, ABI was associated with apathy,42 but arterial stiffness
(CFPWV) was not.43
3.2 | Neuroimaging and apathy
The 10 studies using MRI or DTI are presented in Table 2.
Of the three studies examining the association between WMH and
apathy, the two cross‐sectional studies found a significant associa-
tion,30,48 whereas the (smaller) case‐control study did not.49 Again, a
meta‐analysis and quantitative estimation of the WMH and apathy
association were not possible, because of the large differences in the
studies' research designs, the methods of ascertaining WMH (number
or volume), and apathy scales used. It needs to be noted here that,
with 4354 participants, the study by Van Grool et al48 would have
largely outweighed the findings of the other studies in any meta‐anal-
ysis, since the other studies had much smaller samples.
Mean white matter diffusivity (MD) was associated with apathy in
specific areas in the small‐scale study by Cacciari et al,45 but not in the
study by Moonen et al.50 Other DTI measures (FA, axial diffusivity,
and radial diffusivity) were not associated with apathy.50
Evaluating the data of 802 participants, Xu et al51 found the partic-
ipants who had suffered a single cerebral microbleed to show signifi-
cantly more apathy than participants without cerebral microbleeds.
Of the three studies examining looking at cortical thickness and
apathy, two studies found an association between apathy and a
reduced thickness of the temporal lobe.32, 33 No associations were
reported for apathy and the entorhinal cortex, the orbitofrontal cortex,
FIGURE 1 Flow chart of the inclusion of
studies
WOUTS ET AL.6or the middle frontal gyrus,47 while no association or even an inverse
association was found between apathy and the anterior cingulate.31,47
However, in a model in which apathy was adjusted for depressive
symptom severity, apathy was found to be associated with a more
rapid reduction of the anterior cingulate cortex during follow‐up.47
4 | DISCUSSION
4.1 | Main findings
The results of our review indeed support the hypothesis that SSVD is
related with apathy. More specifically, as peripheral proxies for SSVD,
hypertension and cardiovascular disease were consistently found to
be associated with apathy.9,29,30,42 With the only study examiningABI finding a significant association with apathy while another single
study focusing on arterial stiffness did not,42,43 the results with
respect to other peripheral measures of atherosclerosis were inconclu-
sive. Apathy was, however, also linked to cerebral microbleeds51 and
WMH load.30,48 SSVD was related to white MD; however, a direct
association between white MD and apathy has not been established
yet.45,50 The evidence on the relationship between cortical thickness
and apathy is inconclusive.31,44,47
4.2 | Hypertension, cardiovascular disease, WMH,
and apathy
Both systolic and diastolic blood pressure were associated with apa-
thy,9,30,42 while associations between WMH and apathy (and cerebral








Van der Mast et al, 2008 General population >85 years
Longitudinal 500
CVP GDS‐3A Mean number of CVP: apathy
1.04 (0.11) versus no apathy
0.77 (0.05); P = .02 CVP and
increase in apathy: 0.05
(0.02); P = .007
High (9/9)
Yao et al, 2009 General population Cross‐
sectional 222




Suga‐wara et al, 2011 General population Cross‐
sectional 860
ABI Apathy scale ABI: beta −0.071 (t value
−2.039); P < .05 Systolic
blood pressure: beta −0.056
(t value −1.420); P = .156
High (6/9)
Ligthart et al, 2012 General population Cross‐
sectional 3534
Cerebro‐vascular risk factors GDS‐3A CVP and apathy 1.28 (1.09‐
1.52); P = .004 Systolic
blood pressure is associated
with apathy
High (12/16)
Van Sloten et al, 2016 General population Cross‐
sectional 2058
Arterial stiffness GDS‐3A Arterial stiffness: OR 1.07
(0.96‐1.19)
High (11/16)
Note. High quality: ≥60% of the maximum score.
Abbreviations: ABI, ankle brachial index; CVP, cardiovascular pathologies; GDS‐3A, three apathy items of the geriatric depression scale; OR, odds ratio.
WOUTS ET AL. 7microbleeds and apathy) were found in large‐scale and high‐quality
studies.30,48,51 Although Delrieu et al49 did not find any such evidence,
their study may have been underpowered. Finally, cardiovascular dis-
ease was firmly associated with apathy, not only cross sectionally
but also longitudinally.9,29
Although its etiology is not fully understood, WMH reflects ische-
mic arteriolosclerosis in the brain27 and is related to congenital heart
disease, hypertension, carotid blood flow, diabetes, and cardiovascular
health.52 WMH may then be seen as consequence of chronic hypo-
perfusion as well as impaired cerebrovascular reactivity. Nonetheless,
blood‐brain‐barrier leakage and myelin‐remodeling problems could
play a role.53 The relation between hypertension, cardiovascular dis-
ease, and WMH could be limited blood flow to the brain and/or arte-
rial stiffness.52-54
How SSVD can lead to apathy is not yet fully understood. Destruc-
tion of limbic or reward pathways is considered as a potential cause.
Indeed, apathy was found to be associated with impaired connectivity
of limbic association tracts in patients with clinical SVD.55 The results
of the DTI studies of white matter connectivity and apathy in SSVD,
however, were not conclusive.45,504.3 | Cortical thinning, SSVD, and apathy
The contradictory findings regarding the relationship between cortical
thickness and apathy might be due to other mechanisms than SSVD
leading to cortical thinning. Cortical thickness and WMH are associ-
ated, but they are not interchangeable.56,57 Cortical thinning in the
parietal lobes, anterior insula, and caudate nuclei bilateral is related
to WMH, but widespread cortical thinning is related to normal agingas well as early Alzheimer's disease.56-58 In the frontal regions, the
temporal regions, and the anterior cingulate, all areas that have been
studied specifically, cortical thinning could be caused by aging as well
as Alzheimer's disease. Our review has shown that associations in the
general population between apathy and the WMH‐related regions of
cortical thinning (parietal lobes, anterior insula, and caudate nuclei)
have not been studied yet. This is a consideration for future research,
more than it is a counterargument for an association between SSVD
and apathy.4.4 | The vascular apathy hypothesis and the
vascular depression hypothesis
Depression can be a confounder when looking for the relationship
between vascular disease and apathy, since apathy may be a symptom
of depression (anhedonia), while it has also been related to vascular
disease.25,59
Of the 14 studies we reviewed, 12 controlled for depression.9,29-
31,42-45,47,49-51 In three of these latter studies, the GDS was used as
a measure of both apathy and depression,9,29,43 and in five arti-
cles,31,44,47,49,50 the GDS was used as a measure of depression, includ-
ing the three apathy items of this scale. Since these GDS apathy items
show a low sensitivity and a high specificity as a measure of apathy in
older populations,37 correction for depression measured by the GDS
may imply that apathy was also corrected for attenuating the SSVD‐
apathy association. If depression was overcorrected for in these stud-
ies, the associations between SSVD and apathy may also have been
stronger than the statistics now shown.
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MRI Cortical thickness Neuropsychiatric
Inventory apathy
scale
Entorhinal cortex: rate of
change: 0.001 (0.001)
Orbitofrontal cortex:
rate of change: −6e‐4
(0.001) Middle frontal
gyrus: rate of change:
14.5e‐4 (0.001) Anterior
cingulate cortex: rate of
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P < .1; model corrected
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Note. High quality: ≥60% of the maximum score.
Abbreviations: DTI, diffusion tensor imaging; FDG‐PET, fludeoglucose positron‐emission tomography; GDS‐3A, three apathy items of the geriatric depres-
sion scale; MCI, minimal cognitive impairment; MRI, magnetic resonance imaging; WMH, white matter hyperintensities.
WOUTS ET AL.8On the other hand, the role of apathy in the vascular depression
hypothesis is often not accounted for in research, while it may poten-
tially act as a confounder. In patients with clinical SVD, apathy wasassociated with reduced white matter integrity, while depression was
not, when apathy was controlled for.19,21 Arguably, with the emerging
evidence for the vascular apathy hypothesis, one may wonder
WOUTS ET AL. 9whether in research of the vascular depression hypothesis apathy was
and is adequately corrected for.5 | LIMITATIONS
As stated, most of the research we reviewed was cross sectional,
preventing us from establishing whether SSVD precedes apathy,
while we were also unable to determine whether more SSVD leads
to higher levels of apathy. An alternative explanation for an apathy‐
SSVD or an SSVD‐apathy relationship in cross‐sectional designs is
that apathy leads to poorer cardiovascular outcomes because of dif-
ferences in health behaviours.14 Does an association between CVRF
and apathy then reflect the concept of vascular apathy our does it
(partially) reflect differences in health behaviors that are caused by
apathy? Nevertheless, the findings of an increase in the incidence of
apathy with more cardiovascular pathologies29 point towards CVRF
as an etiological factor in apathy (and not only the reverse
mechanism).
Another methodological issue is the use of many different proxies
for SSVD. The use of a broad array of SSVD proxies has negative con-
sequences for the comparability of the research and precludes meta‐
analysis to estimate the magnitude of associations found. Nonethe-
less, generalizability increases when increasing levels of apathy are
associated with widely different proxies for SSVD.
Finally, of the many different apathy scales that were employed,
the AES and the NPI apathy subscale were the only tools that are well
validated,35,36 which is why we cannot rule out that the use of the
other apathy scales may have negatively affected the quality of the
results reported.6 | CONCLUSION
The studies published to date show that WMH, cerebral microbleeds,
cardiovascular disease, hypertension, and ABI are associated with apa-
thy in the general population. However, as most studies were cross
sectional in nature, the directions of the associations remain unclear
and might be reciprocal/bidirectional. Finally, although the hypothesis
of vascular apathy is supported by the available literature, more pro-
spective evidence is needed.CONFLICT OF INTEREST
All authors declare that they have no conflicts of interest.FUNDING INFORMATION
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